Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Morgan, Goujon"'
Autor:
Chloé Drozd, Elsa Curtit, Quentin Jacquinot, Charlène Marquine, Laura Mansi, Loïc Chaigneau, Erion Dobi, Julien Viot, Guillaume Meynard, Marie-Justine Paillard, Morgan Goujon, Pauline Roux, Dewi Vernerey, Valérie Gillet, Hubert Bourdin, Silvio Galli, Nathalie Meneveau, Fabienne Mougin
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Up to 70% of breast cancer patients report symptoms of insomnia during and after treatment. Despite the ubiquity of insomnia symptoms, they are under-screened, under-diagnosed and poorly managed in breast cancer patients. Sleep me
Externí odkaz:
https://doaj.org/article/5473dfa5db4749b08b82dda664fb277d
Autor:
Mylene Wespiser, Lucia Carril-Ajuria, Blazevic Ilfad, Constance Thibault, Aude Flechon, Sophie Martin, Mathieu Laramas, Delphine Borchiellini, Camille Simon, Hakim Mahammedi, Claude Linassier, Morgan Goujon, Sonia Zaibet, Frederic Rolland, Laurence Albiges, Aurelia Meurisse, Antoine Falcoz, Antoine Thiery-Vuillemin
Publikováno v:
Journal of Clinical Oncology. 41:618-618
618 Background: Muscle metastases (MM) are among rare secondary locations in renal cell carcinoma (RCC). Current guidelines do not provide specific advice on the management of these patients. There is a lack of scientific literature on the subject, m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3513e20792309887ac30e2e47a6e0656
https://doi.org/10.1200/jco.2023.41.6_suppl.618
https://doi.org/10.1200/jco.2023.41.6_suppl.618
Autor:
Antoine El, Kaddissi, Guillemette Guilhem, Ducleon, Félix, Lefort, Garvey, Mezepo, Alexandre, Frontczak, Morgan, Goujon, Guillaume, Mouillet, Hamadi, Almotlak, Marine, Gross-Goupil, Antoine, Thiery-Vuillemin
Publikováno v:
Bulletin du Cancer. 109:2S19-2S30
Until recently, the first-line treatments used in metastatic renal cell carcinoma were based on first-generation anti-VEGFR (vascular endothelial growth factor receptor) tyrosine kinase inhibitors (TKIs) as monotherapy. Trials combining immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c34e3fed6db6c28aecf0a7fe494f9cb7
https://doi.org/10.1016/s0007-4551(22)00235-1
https://doi.org/10.1016/s0007-4551(22)00235-1
Autor:
Aurélia Meurisse, Fabien Calcagno, Morgan Goujon, Ouiza Manseur, Guillaume Mouillet, Alexandre Frontczak, Diane Berthod, Noémie Gassian, Antoine Thiery-Vuillemin, Dewi Vernerey, Elise Robert
Publikováno v:
Bulletin du cancer. 107(5S)
Summary Background Metastatic Squamous cell Penile Carcinoma (mSCPC) is an orphan disease with a virally induced oncogenesis. PD-L1 expression rate is around 60% with a strong correlation between PD-L1 in the primary tumour and metastases. The first
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765d238fbfa6ce1f5bb1d49215bbac7b
https://pubmed.ncbi.nlm.nih.gov/32620211
https://pubmed.ncbi.nlm.nih.gov/32620211
Autor:
Noemie Gassian, Anne-Laure Clairet, Morgan Goujon, Alexandre Frontczak, Fabien Calcagno, Hamadi Almotlak, Guillaume Mouillet, Tristan Maurina, Ulrich Stein, Thierry Nguyen, Marie Jeannin, Antoine Thiery-Vuillemin
Publikováno v:
Journal of Clinical Oncology. 40:111-111
111 Background: Prostate cancer often occurs in an elderly population, at higher risk of drug-drug interactions (DDIs). There is a medical need to increase the knowledge of DDI prevalence and their severity among patients coming from routine care. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::040231e58ef6127486382d85fa3b5b14
https://doi.org/10.1200/jco.2022.40.6_suppl.111
https://doi.org/10.1200/jco.2022.40.6_suppl.111
Autor:
Elodie Klajer, Morgan Goujon, Fabien Calcagno, Benoîte Méry, Thierry Nguyen Tan Hon, Guillaume Mouillet, Friederike Schlurmann-Constans, Louis Garnier, Antoine Thiery-Vuillemin
Publikováno v:
Seminars in oncology. 47(2-3)
Background Patients with severe renal impairment or undergoing hemodialysis are usually excluded from clinical trials. Available data regarding safety and activity of systemic therapies (ST) in hemodialyzed patients are scarce. Methods Clinical data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b45269aa3d97ddadec21b6d919453b36
https://pubmed.ncbi.nlm.nih.gov/32522380
https://pubmed.ncbi.nlm.nih.gov/32522380
Autor:
A. Frontczak, Thierry Nguyen, Ulrich Stein, Hamadi Almotlak, Morgan Goujon, Tristan Maurina, Guillaume Mouillet, Emilie Charton, Amélie Anota, Calcagno Fabien, Antoine Thiery-Vuillemin
Publikováno v:
Journal of Clinical Oncology. 39:54-54
54 Background: A potential link between Health-Related Quality of life (HRQoL) and oncologic outcomes such as overall survival or progression-free survival has been underlined for endocrine therapies in patients with metastatic castrate resistant pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1353e1d42dd9e248ac0ac897a9304671
https://doi.org/10.1200/jco.2021.39.6_suppl.54
https://doi.org/10.1200/jco.2021.39.6_suppl.54